The Thromboembolic Continuum in Transcatheter Mitral Valve Repair: A Comprehensive Review - PubMed
3 days ago
- #mitral valve repair
- #stroke risk
- #thromboembolism
- M-TEER is a key, low-risk treatment for severe mitral regurgitation.
- Thromboembolic risk varies from pre-procedural to post-procedural stages.
- Atrial cardiomyopathy creates a prothrombotic environment before the procedure.
- Device time during the procedure is a key predictor of embolic burden.
- There's a gap between common subclinical lesions on MRI and rare overt neurological deficits.
- Post-procedural management is shifting from standardized to individualized antithrombotic strategies.
- Left atrial appendage occlusion may play a role in reducing risks.
- Technologies like digital twins and AI could help optimize procedural planning and safety.